NCT00407303 2016-07-21Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)Teva Branded Pharmaceutical Products R&D, Inc.Phase 1/2 Completed24 enrolled